National Health downgraded by Wells Fargo with a new price target
$NHI
Real Estate Investment Trusts
Real Estate
Wells Fargo downgraded National Health from Overweight to Equal Weight and set a new price target of $86.00 from $81.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/1/2024 | $81.00 → $86.00 | Overweight → Equal Weight | Wells Fargo |
| 9/24/2024 | $92.00 | Buy | BofA Securities |
| 3/12/2024 | $67.00 | Market Perform → Outperform | BMO Capital Markets |
| 2/26/2024 | $55.00 → $63.00 | Equal Weight → Overweight | Wells Fargo |
| 2/26/2024 | $57.00 → $64.00 | Neutral → Outperform | Wedbush |
| 1/30/2024 | $69.00 | Buy | Deutsche Bank |
| 10/3/2023 | $54.00 | Neutral | Wedbush |
| 9/28/2023 | $54.00 | Hold | Berenberg |
8-K - NATIONAL HEALTH INVESTORS INC (0000877860) (Filer)
8-K - NATIONAL HEALTH INVESTORS INC (0000877860) (Filer)
DEFA14A - NATIONAL HEALTH INVESTORS INC (0000877860) (Filer)
4 - NATIONAL HEALTH INVESTORS INC (0000877860) (Issuer)
4 - NATIONAL HEALTH INVESTORS INC (0000877860) (Issuer)
4 - NATIONAL HEALTH INVESTORS INC (0000877860) (Issuer)
4 - NATIONAL HEALTH INVESTORS INC (0000877860) (Issuer)
4 - NATIONAL HEALTH INVESTORS INC (0000877860) (Issuer)
Wells Fargo downgraded National Health from Overweight to Equal Weight and set a new price target of $86.00 from $81.00 previously
BofA Securities initiated coverage of National Health with a rating of Buy and set a new price target of $92.00
BMO Capital Markets upgraded National Health from Market Perform to Outperform and set a new price target of $67.00